China Universal Asset Management Company’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $854K | Buy |
16,011
+41
| +0.3% | +$2.19K | 0.08% | 186 |
|
|
2025
Q1 | $646K | Buy |
15,970
+1,170
| +8% | +$47.4K | 0.06% | 221 |
|
|
2024
Q4 | $412K | Buy |
14,800
+1,446
| +11% | +$40.2K | 0.04% | 268 |
|
|
2024
Q3 | $383K | Buy |
13,354
+5,230
| +64% | +$150K | 0.04% | 247 |
|
|
2024
Q2 | $191K | Sell |
8,124
-2,676
| -25% | -$62.8K | 0.03% | 249 |
|
|
2024
Q1 | $273K | Buy |
10,800
+4,351
| +67% | +$110K | 0.03% | 253 |
|
|
2023
Q4 | $151K | Buy |
6,449
+5,023
| +352% | +$117K | 0.03% | 235 |
|
|
2023
Q3 | $72.1K | Buy |
1,426
+701
| +97% | +$35.5K | 0.02% | 215 |
|
|
2023
Q2 | $33.9K | Buy |
725
+91
| +14% | +$4.25K | 0.01% | 229 |
|
|
2023
Q1 | $24.3K | Buy |
634
+159
| +33% | +$6.08K | 0.01% | 202 |
|
|
2022
Q4 | $26K | Buy |
475
+123
| +35% | +$6.74K | 0.01% | 163 |
|
|
2022
Q3 | $12K | Buy |
+352
| New | +$12K | 0.01% | 186 |
|